Winona has introduced a comprehensive 2025 telehealth platform designed to support women navigating perimenopause, menopause and post-menopause. According to the company, the service offers expert-guided, personalized hormone therapy delivered through an online intake process, enabling licensed healthcare providers to tailor recommendations based on individuals’ medical history and symptoms.
The company said that Winona combines medical oversight, convenience and education—conducting assessments via an intake questionnaire, prescribing hormone therapy as needed, and delivering prescriptions directly to users’ homes. The platform also emphasizes patient education to promote informed decision-making.
Winona claims that its model distinguishes itself from over-the-counter supplements and traditional in-clinic hormone therapy by offering personalized, evidence-informed guidance with greater accessibility and reduced stigma. The company noted that its service allows for ongoing adjustments, privacy, and simplified integration into daily life.
The platform offers flexible pricing, including one-time consultations, monthly prescription packages, and longer-term subscriptions. The company advises that actual prices and packages are available on its official website and may change over time.
According to the company, safety is ensured through professional oversight and a thorough intake process, though it cautions that hormone therapy carries potential risks and should be used responsibly. Users are encouraged to provide their full medical history, follow provider instructions, and stay in communication for plan reassessment.
